Myers RP - Search Results

1

Sarcoidosis and interferon therapy: report of five cases and review of the literature.

Leclerc S, Myers RP, Moussalli J, Herson S, Poynard T, Benveniste O. Leclerc S, et al. Among authors: myers rp. Eur J Intern Med. 2003 Jul;14(4):237-243. doi: 10.1016/s0953-6205(03)00078-5. Eur J Intern Med. 2003. PMID: 12919839

2

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.

Myers RP, Poynard T. Myers RP, et al. Cochrane Database Syst Rev. 2002;(4):CD003617. doi: 10.1002/14651858.CD003617. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2013 Jan 31;(1):CD003617. doi: 10.1002/14651858.CD003617.pub2 PMID: 12519606 Updated. Review.

3

The impact of prior hepatitis B virus infection on liver histology and the response to interferon therapy in chronic hepatitis C.

Myers RP, Thibault V, Poynard T. Myers RP, et al. J Viral Hepat. 2003 Mar;10(2):103-10. doi: 10.1046/j.1365-2893.2003.00407.x. J Viral Hepat. 2003. PMID: 12614466

4

Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C.

Cacoub P, Ratziu V, Myers RP, Ghillani P, Piette JC, Moussalli J, Poynard T; Multivirc Group. Cacoub P, et al. Among authors: myers rp. J Hepatol. 2002 Jun;36(6):812-8. doi: 10.1016/s0168-8278(02)00067-3. J Hepatol. 2002. PMID: 12044533

5

Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy.

Myers RP, Benhamou Y, Bochet M, Thibault V, Mehri D, Poynard T. Myers RP, et al. AIDS. 2004 Jan 2;18(1):75-9. doi: 10.1097/00002030-200401020-00009. AIDS. 2004. PMID: 15090832

6

The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C.

Myers RP, Patel K, Pianko S, Poynard T, McHutchison JG. Myers RP, et al. J Viral Hepat. 2003 Jan;10(1):16-22. doi: 10.1046/j.1365-2893.2003.00387.x. J Viral Hepat. 2003. PMID: 12558907

7

Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trial.

Poynard T, Marcellin P, Bissery A, Myers RP, Moussalli J, Degos F, Dhumeaux D, Riachi G, Bronowicki JP, Brissot P, Buffet C, Serfaty L, Naveau S, Sogni P, Beaugrand M, Gayno S, Larrey D, Samuel D, Eugene C, Pol S, Bedossa P, Daurat V, Chaumet-Riffaud P; GER-CYT-RIBANON group. Poynard T, et al. Among authors: myers rp. J Viral Hepat. 2003 May;10(3):197-204. doi: 10.1046/j.1365-2893.2003.00427.x. J Viral Hepat. 2003. PMID: 12753338 Clinical Trial.

8

Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin.

Poynard T, McHutchison J, Manns M, Myers RP, Albrecht J. Poynard T, et al. Among authors: myers rp. Hepatology. 2003 Aug;38(2):481-92. doi: 10.1053/jhep.2003.50319. Hepatology. 2003. PMID: 12883493 Clinical Trial.

9

[What are the indications for treatment of acute hepatitis C?].

Myers RP, Regimbeau C, Moussalli J, Ratziu V, Di Martino V, Thabut D, Bernard B, Benhamou Y, Poynard T. Myers RP, et al. Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B188-93. Gastroenterol Clin Biol. 2002. PMID: 12180287 Review. French. No abstract available.

10

Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure.

Di Martino V, Lebray P, Myers RP, Pannier E, Paradis V, Charlotte F, Moussalli J, Thabut D, Buffet C, Poynard T. Di Martino V, et al. Among authors: myers rp. Hepatology. 2004 Dec;40(6):1426-33. doi: 10.1002/hep.20463. Hepatology. 2004. PMID: 15565616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

364 results

Search Page

Filters